Oura

Oura delayed pricing on its Nasdaq offering hours before shares were set to trade, saying demand was strong but conditions were not.

Apple hasn't decided to ship it, and Bloomberg's reporting puts any release in 2028 at the earliest, so the Apple Watch stays Apple's only fitness wearable for years yet.

Oura set its IPO at 50 million shares for $40 to $44 each. Existing shareholders are selling 36.5 million of them.

Oura's prospectus says 94% of ring buyers take the subscription and the company made $60.8 million in nine months. It also expects future features to be regulated as medical devices.

Ten variants under one Brazilian certificate is a size range, and it puts Garmin's unannounced ring between the current Oura and the one before it.

The IPO filing ties an $84.4 million rise in warranty expense to the fault, and names none of the affected batches.

A patent application published this week describes a migraine prediction score built from sleep, temperature and heart data the ring already collects.

Both numbers in this case are Oura's own. The 21% that does not agree falls on sleep staging, which is the part of the score people actually read.